Photo credit: Borja Ruiz Rodriguez/MSFTime for $5
Photograph by Maya Abu Ata
Access to essential medicines and diagnostics for people with NCDs is severely lacking, including in emergency and humanitarian settings.
Médecins Sans Frontières calls on WHO to:
- Urgently issue clinical guidance for public health programmes on the management of people with type 1 and 2 diabetes, including the use of newer medicines for diabetes mostly available in high-income settings only;
- Support member states in developing harmonised national and regional guidance following WHO 2021 hypertension guidelines;
- Develop programmatic guidance to support the integration of diabetes and hypertension care into primary care, including the principle of differentiated service delivery that has successfully enabled scale up of HIV care;
- Ensure price transparency for all diabetes medicines in the Model List of Essential Medicines, including insulin in all formulations, as outlined in the diabetes resolution; and
- Support member states in pooled procurement of NCD medicines with fair prices based on cost of production data.